| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-92506-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43928 | |||
| BSA Free | NBP2-52875-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-80611-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49220-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90297-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74597 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-92947-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-96907-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52555-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-22212-0.025ml | |||
![Western Blot: TIF1 alpha Antibody [NBP1-92506] - Analysis in Caco-2 cells transfected with control siRNA, target specific siRNA probe #1 and #2,. Remaining relative intensity is presented. Loading control: Anti-GAPDH.](http://images.novusbio.com/fullsize/TIF1-alpha-Antibody-Western-Blot-NBP1-92506-img0013.jpg "<b>Genetic Strategies Validation. </b>Western Blot: TIF1 alpha Antibody [NBP1-92506] - Analysis in Caco-2 cells transfected with control siRNA, target specific siRNA probe #1 and #2,. Remaining relative intensity is presented. Loading control: Anti-GAPDH.")
![<b>Genetic Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: TIF1 alpha Antibody [NBP1-92506] - Staining of human cell line U-251 MG shows localization to nucleoplasm. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/TIF1-alpha-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-92506-img0006.jpg)
![Immunohistochemistry-Paraffin: TIF1 alpha Antibody [NBP1-92506] - Staining of human testis shows moderate nuclear positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/TIF1-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-92506-img0012.jpg)
![Immunohistochemistry-Paraffin: TIF1 alpha Antibody [NBP1-92506] - Staining of human testis shows moderate nuclear positivity in cells in seminiferous ducts while additional moderate cytoplasmic in Leydig cells.](http://images.novusbio.com/fullsize/TIF1-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-92506-img0007.jpg)
![Immunohistochemistry-Paraffin: TIF1 alpha Antibody [NBP1-92506] - Staining of human small intestine shows moderate nuclear positivity in glandular cells.](http://images.novusbio.com/fullsize/TIF1-alpha-Antibody-Western-Blot-NBP1-92506-img0010.jpg)
![Immunohistochemistry-Paraffin: TIF1 alpha Antibody [NBP1-92506] - Staining of human placenta shows moderate nuclear and weak cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/TIF1-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-92506-img0011.jpg)
![Western Blot: Annexin A1 Antibody (CL0199) [NBP2-52875] - Analysis of extracts from U-251 cells, transfected with: control siRNA, target specific siRNA probe #1, target specific siRNA probe #2, using Anti-ANXA1 monoclonal antibody. Downregulation of antibody signal confirms target specificity. Remaining intensity is presented. Loading control: Anti-GAPDH.](http://images.novusbio.com/fullsize/Annexin-A1-Antibody-CL0199-Western-Blot-NBP2-52875-img0007.jpg "<b>Genetic Strategies Validation. </b>Western Blot: Annexin A1 Antibody (CL0199) [NBP2-52875] - Analysis of extracts from U-251 cells, transfected with: control siRNA, target specific siRNA probe #1, target specific siRNA probe #2, using Anti-ANXA1 monoclonal antibody. Downregulation of antibody signal confirms target specificity. Remaining intensity is presented. Loading control: Anti-GAPDH.")
![<b>Genetic Strategies Validation. </b>Immunohistochemistry-Paraffin: Annexin A1 Antibody (CL0199) [NBP2-52875] - Staining of human placenta shows strong immunoreactivity in the trophoblast cells.](http://images.novusbio.com/fullsize/Annexin-A1-Antibody-CL0199-Immunohistochemistry-Paraffin-NBP2-52875-img0005.jpg)
![Immunohistochemistry-Paraffin: Annexin A1 Antibody (CL0199) [NBP2-52875] - Staining of human bone marrow shows strong nuclear immunoreactivity in a subset of lymphoid cells.](http://images.novusbio.com/fullsize/Annexin-A1-Antibody-CL0199-Immunohistochemistry-Paraffin-NBP2-52875-img0001.jpg)
![Immunohistochemistry-Paraffin: Annexin A1 Antibody (CL0199) [NBP2-52875] - Staining of human bronchus shows distinct positivity in ciliated epithelial cells.](http://images.novusbio.com/fullsize/Annexin-A1-Antibody-CL0199-Immunohistochemistry-Paraffin-NBP2-52875-img0002.jpg)
![Immunohistochemistry-Paraffin: Annexin A1 Antibody (CL0199) [NBP2-52875] - Staining of human fallopian tube shows strong positivity in the glandular cells.](http://images.novusbio.com/fullsize/Annexin-A1-Antibody-CL0199-Immunohistochemistry-Paraffin-NBP2-52875-img0003.jpg)
![Immunohistochemistry-Paraffin: Annexin A1 Antibody (CL0199) [NBP2-52875] - Staining of human lung shows nuclear positivity in a subset of pneumocytes and lymphoid cells.](http://images.novusbio.com/fullsize/Annexin-A1-Antibody-CL0199-Immunohistochemistry-Paraffin-NBP2-52875-img0004.jpg)
![Immunohistochemistry-Paraffin: 14-3-3 beta/alpha Antibody [NBP1-80611] - Analysis in human cerebral cortex and pancreas tissues. Corresponding YWHAB RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/14-3-3-beta-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-80611-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: 14-3-3 beta/alpha Antibody [NBP1-80611] - Analysis in human cerebral cortex and pancreas tissues. Corresponding YWHAB RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: 14-3-3 beta/alpha Antibody [NBP1-80611] - Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG sp](http://images.novusbio.com/fullsize/14-3-3-beta-alpha-Antibody-Western-Blot-NBP1-80611-img0005.jpg)
![Immunohistochemistry-Paraffin: 14-3-3 beta/alpha Antibody [NBP1-80611] - Staining of human pancreas shows very weak positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/14-3-3-beta-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-80611-img0010.jpg)
![Western Blot: 14-3-3 beta/alpha Antibody [NBP1-80611] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells). Lane 2: NBT-II cell lysate (Rat Wistar bladder tumor cells).](http://images.novusbio.com/fullsize/14-3-3-beta-alpha-Antibody-Western-Blot-NBP1-80611-img0004.jpg)
![Immunohistochemistry-Paraffin: 14-3-3 beta/alpha Antibody [NBP1-80611] - Staining of human cerebral cortex shows moderate to strong cytoplasmic positivity in neurons.](http://images.novusbio.com/fullsize/14-3-3-beta-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-80611-img0007.jpg)
![Immunohistochemistry-Paraffin: 14-3-3 beta/alpha Antibody [NBP1-80611] - Staining of human cerebellum shows moderate to strong cytoplasmic positivity in Purkinje cells.](http://images.novusbio.com/fullsize/14-3-3-beta-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-80611-img0008.jpg)
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: 14-3-3 beta/alpha Antibody [NBP1-80611] - Staining of human skin shows moderate to strong cytoplasmic positivity in epidermal cells.](http://images.novusbio.com/fullsize/14-3-3-beta-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-80611-img0009.jpg)
![Western Blot: MAP4K6 Antibody [NBP2-49220] - Analysis in human cell lines A-549 and U2OS using anti-MINK1 antibody. Corresponding MINK1 RNA-seq data are presented for the same cell lines. Loading control: anti-GAPDH.](http://images.novusbio.com/fullsize/MAP4K6-Antibody-Western-Blot-NBP2-49220-img0004.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: MAP4K6 Antibody [NBP2-49220] - Analysis in human cell lines A-549 and U2OS using anti-MINK1 antibody. Corresponding MINK1 RNA-seq data are presented for the same cell lines. Loading control: anti-GAPDH.")
![Immunohistochemistry-Paraffin: PTK9 Antibody [NBP1-90297] - Staining of human urinary bladder shows moderate cytoplasmic positivity in urothelial cells.](http://images.novusbio.com/fullsize/PTK9-Antibody-Immunohistochemistry-Paraffin-NBP1-90297-img0016.jpg "Immunohistochemistry-Paraffin: PTK9 Antibody [NBP1-90297] - Staining of human urinary bladder shows moderate cytoplasmic positivity in urothelial cells.")
![Immunohistochemistry-Paraffin: PTK9 Antibody [NBP1-90297] - Staining of human colon shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/PTK9-Antibody-Immunohistochemistry-Paraffin-NBP1-90297-img0013.jpg)
![Immunohistochemistry-Paraffin: PTK9 Antibody [NBP1-90297] - Staining of human prostate shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/PTK9-Antibody-Immunohistochemistry-Paraffin-NBP1-90297-img0014.jpg)
![Immunohistochemistry-Paraffin: PTK9 Antibody [NBP1-90297] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/PTK9-Antibody-Immunohistochemistry-Paraffin-NBP1-90297-img0015.jpg)
![Simple Western: PTK9 Antibody [NBP1-90297] - Electropherogram image(s) of corresponding Simple Western lane view. PTK9 antibody was used at 1:40 dilution on RT-4 and U-251MG lysate(s).](http://images.novusbio.com/fullsize/PTK9-Antibody-Simple-Western-NBP1-90297-img0008.jpg)
![Western Blot: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Analysis of extracts (35ug) from 9 different cell lines by using anti-TRIB2 monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Western-Blot-NBP1-48030-img0010.jpg "Western Blot: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Analysis of extracts (35ug) from 9 different cell lines by using anti-TRIB2 monoclonal antibody.")
![Immunocytochemistry/Immunofluorescence: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of COS7 cells using anti-TRIB2 mouse monoclonal antibody .](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunocytochemistry-Immunofluorescence-NBP1-48030-img0011.jpg)
![Immunohistochemistry-Paraffin: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of paraffin-embedded Human endometrium tissue using anti-TRIB2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunohistochemistry-Paraffin-NBP1-48030-img0009.jpg)
![Flow Cytometry: TRIB2 Antibody (OTI8D11) [NBP1-48030] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-TRIB2 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Flow-Cytometry-NBP1-48030-img0001.jpg)
![Western Blot: TRIB2 Antibody (OTI8D11) [NBP1-48030] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TRIB2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-TRIB2.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Western-Blot-NBP1-48030-img0002.jpg)
![Immunohistochemistry-Paraffin: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-TRIB2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunohistochemistry-Paraffin-NBP1-48030-img0003.jpg)
![Immunohistochemistry-Paraffin: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-TRIB2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunohistochemistry-Paraffin-NBP1-48030-img0004.jpg)
![Immunohistochemistry-Paraffin: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-TRIB2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunohistochemistry-Paraffin-NBP1-48030-img0005.jpg)
![Immunohistochemistry-Paraffin: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-TRIB2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunohistochemistry-Paraffin-NBP1-48030-img0006.jpg)
![Immunohistochemistry-Paraffin: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of paraffin-embedded Carcinoma of Human kidney tissue using anti-TRIB2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunohistochemistry-Paraffin-NBP1-48030-img0007.jpg)
![Immunohistochemistry-Paraffin: TRIB2 Antibody (OTI8D11) [NBP1-48030] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-TRIB2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/TRIB2-Antibody-OTI8D11-Immunohistochemistry-Paraffin-NBP1-48030-img0008.jpg)
![Western Blot: CD44 Antibody [NBP2-92947] - Analysis of extracts of various cell lines, using CD44 antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/CD44-Antibody-Western-Blot-NBP2-92947-img0005.jpg "Western Blot: CD44 Antibody [NBP2-92947] - Analysis of extracts of various cell lines, using CD44 antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit. Exposure time: 10s.")
![Immunocytochemistry/Immunofluorescence: CD44 Antibody [NBP2-92947] - Analysis of RAW264.7 cells using CD44 at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/CD44-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-92947-img0004.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody [NBP2-92947] - Human lung cancer using CD44 Rabbit pAb at dilution of 1:250 (40x lens).](http://images.novusbio.com/fullsize/CD44-Antibody-Immunohistochemistry-Paraffin-NBP2-92947-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody [NBP2-92947] - Analysis of A431 cells using CD44 at dilution of 1:200. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/CD44-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-92947-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody [NBP2-92947] - Analysis of HeLa cells using CD44 at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/CD44-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-92947-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody [NBP2-92947] - Analysis of HeLa cells using CD44 at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/CD44-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-92947-img0003.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody [NBP2-92947] - Human esophageal cancer using CD44 Rabbit pAb at dilution of 1:250 (40x lens).](http://images.novusbio.com/fullsize/CD44-Antibody-Immunohistochemistry-Paraffin-NBP2-92947-img0007.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: CD44 Antibody [NBP2-92947] - Analysis of extracts of HeLa cells, using CD44 antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/CD44-Antibody-Knockout-Validated-NBP2-92947-img0006.jpg)
![Western Blot: p38 alpha Antibody [NB110-96907] - Western blot analysis of Human cancer cell lines showing detection of p38 alpha protein using Rabbit Anti-p38 alpha Polyclonal Antibody (NB110-96907). Load: 15 ugprotein. Block: 1.5% BSA for 30 minutes at RT. Primary Antibody: Rabbit Anti-p38 alpha Polyclonal Antibody (NB110-96907) at 1:4000 for 2 hours at RT. Secondary Antibody: Donkey Anti-Rabbit IgG: HRP for 1 hour at RT.](http://images.novusbio.com/fullsize/p38-alpha-Antibody-Western-Blot-NB110-96907-img0008.jpg "Western Blot: p38 alpha Antibody [NB110-96907] - Western blot analysis of Human cancer cell lines showing detection of p38 alpha protein using Rabbit Anti-p38 alpha Polyclonal Antibody (NB110-96907). Load: 15 ugprotein. Block: 1.5% BSA for 30 minutes at RT. Primary Antibody: Rabbit Anti-p38 alpha Polyclonal Antibody (NB110-96907) at 1:4000 for 2 hours at RT. Secondary Antibody: Donkey Anti-Rabbit IgG: HRP for 1 hour at RT.")
![Immunocytochemistry/Immunofluorescence: p38 alpha Antibody [NB110-96907] - Analysis using Rabbit Anti-p38 Polyclonal Antibody . Tissue: HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-p38 Polyclonal Antibody at 1:100 for 12 hours at 4 degrees C. Secondary Antibody: FITC Goat Anti-Rabbit (green) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Mitochondrion. Cytoplasm. Nucleus. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-p38 Antibody. (C) Composite.](http://images.novusbio.com/fullsize/p38-alpha-Antibody-Immunocytochemistry-Immunofluorescence-NB110-96907-img0007.jpg)
![Western Blot: p38 alpha Antibody [NB110-96907] - CtsK & NFATc1 expression levels were decreased during osteoclastogenesis by PSTP-3,5-Me treatment. (A) mRNA expression levels of osteoclast-specific markers were determined by RT-PCR in 0 or 6 µM PSTP-3,5-Me-treated cells. *p < 0.05, & **p < 0.01 indicate the statistically significant difference between non-PSTP-3,5-Me-treated groups (0 µM) & PSTP-3,5-Me-treated groups (6 µM) on each day. Mean ± standard error. (B) Western blotting was performed to determine phosphorylation of NF-kB, p-38, ERK1/2, & JNK. Cells were pre-treated with 6 µM PSTP-3,5-Me or vehicle (Ctrl) for 2 h, & then treated with RANKL for the indicated times. beta -Actin expression level was used as a loading control. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31540026), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-96907_rabbit-polyclonal-p38-alpha-antibody-31020241534327.jpg)
![Western Blot: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis using RSK3 mouse mAb against Hela (1), A431 (2), HEK293 (3), Jurkat (4), HepG2 (5), MCF-7 (6), NIH/3T3 (7) cell lysate.](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-Western-Blot-NBP2-52555-img0009.jpg "Western Blot: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis using RSK3 mouse mAb against Hela (1), A431 (2), HEK293 (3), Jurkat (4), HepG2 (5), MCF-7 (6), NIH/3T3 (7) cell lysate.")
![Immunocytochemistry/Immunofluorescence: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis of A431 cells using RPS6KA2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-Immunofluorescence-NBP2-52555-img0002.jpg)
![Immunohistochemistry-Paraffin: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis of paraffin-embedded lung cancer tissues using RPS6KA2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-Immunohistochemistry-Paraffin-NBP2-52555-img0004.jpg)
![Flow Cytometry: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis of Hela cells using RPS6KA2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-Flow-Cytometry-NBP2-52555-img0001.jpg)
![Western Blot: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis using RPS6KA2 mAb against human RPS6KA2 (AA: 415-734) recombinant protein. (Expected MW is 62 kDa)](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-Western-Blot-NBP2-52555-img0005.jpg)
![Western Blot: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis using RPS6KA2 mAb against HEK293 (1) and RPS6KA2 (AA: 415-734)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-Western-Blot-NBP2-52555-img0007.jpg)
![Immunohistochemistry-Paraffin: RSK3 Antibody (3C4C8) [NBP2-52555] - Analysis of paraffin-embedded cervical cancer tissues using RPS6KA2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-Immunohistochemistry-Paraffin-NBP2-52555-img0003.jpg)
![ELISA: RSK3 Antibody (3C4C8) [NBP2-52555] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/RSK3-Antibody-3C4C8-ELISA-NBP2-52555-img0008.jpg)
![Western Blot: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Analysis using PI 3 Kinase p85 alpha mAb against human PI 3 Kinase p85 alpha recombinant protein. (Expected MW is 53.4 kDa)](http://images.novusbio.com/fullsize/PI-3-Kinase-p85-alpha-Antibody-6G10-Western-Blot-NBP2-22212-img0007.jpg "Western Blot: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Analysis using PI 3 Kinase p85 alpha mAb against human PI 3 Kinase p85 alpha recombinant protein. (Expected MW is 53.4 kDa)")
![Immunocytochemistry/Immunofluorescence: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Analysis of HepG2 cells using PI 3 Kinase p85 alpha mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/PI-3-Kinase-p85-alpha-Antibody-6G10-Immunocytochemistry-NBP2-22212-img0009.jpg)
![Immunohistochemistry-Paraffin: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Analysis of rectum cancer tissues using PI 3 Kinase p85 alpha mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/PI-3-Kinase-p85-alpha-Antibody-6G10-Immunohistochemistry-Paraffin-NBP2-22212-img0005.jpg)
![Flow Cytometry: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Analysis of NIH3T3 cells using PI 3 Kinase p85 alpha mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/PI-3-Kinase-p85-alpha-Antibody-6G10-Flow-Cytometry-NBP2-22212-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Analysis of HeLa cells using PI 3 Kinase p85 alpha mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/PI-3-Kinase-p85-alpha-Antibody-6G10-Immunocytochemistry-NBP2-22212-img0008.jpg)
![Immunohistochemistry-Paraffin: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Analysis of cervical cancer tissues using PI 3 Kinase p85 alpha mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/PI-3-Kinase-p85-alpha-Antibody-6G10-Immunohistochemistry-Paraffin-NBP2-22212-img0004.jpg)
![ELISA: PI 3-Kinase p85 alpha Antibody (6G10) [NBP2-22212] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng)](http://images.novusbio.com/fullsize/PI-3-Kinase-p85-alpha-Antibody-6G10-ELISA-NBP2-22212-img0006.jpg)
![Western Blot: GSK-3 alpha/beta Antibody (1H8) [NB110-85523] - Analysis: Lane 1: MW marker, Lane 2: 20ug HeLa lysate (heat shocked), Lane 3: 20ug mouse brain lysate, Lane 4: 20ug rat brain lysate, Lane 5: 20ug RK-13 lysate.](http://images.novusbio.com/fullsize/GSK-3-alpha-beta-Antibody-1H8-Western-Blot-NB110-85523-img0003.jpg "Western Blot: GSK-3 alpha/beta Antibody (1H8) [NB110-85523] - Analysis: Lane 1: MW marker, Lane 2: 20ug HeLa lysate (heat shocked), Lane 3: 20ug mouse brain lysate, Lane 4: 20ug rat brain lysate, Lane 5: 20ug RK-13 lysate.")
![Immunohistochemistry-Paraffin: GSK3 alpha/beta Antibody (1H8) [NB110-85523] - Alzgeuner diseased neurons with granulovacuolar degeneration co-stained with GSK alpha/beta Monoclonal Antibody (1H8) (Brown Precipitate).](http://images.novusbio.com/fullsize/GSK3-alpha-beta-Antibody-1H8-Immunohistochemistry-Paraffin-NB110-85523-img0002.jpg)
![Western Blot: TAK1 Antibody (JM73-19) [NBP2-67180] - Western blot analysis of TAK1 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: MCF-7 cell lysate Lane 2: A431 cell lysate](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Western-Blot-NBP2-67180-img0008.jpg "Western Blot: TAK1 Antibody (JM73-19) [NBP2-67180] - Western blot analysis of TAK1 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: MCF-7 cell lysate Lane 2: A431 cell lysate")
![Immunocytochemistry/Immunofluorescence: TAK1 Antibody (JM73-19) [NBP2-67180] - Staining TAK1 in N2A cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunocytochemistry-Immunofluorescence-NBP2-67180-img0007.jpg)
![Immunohistochemistry-Paraffin: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of paraffin-embedded mouse stomach tissue using anti-TAK1 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunohistochemistry-Paraffin-NBP2-67180-img0005.jpg)
![Flow Cytometry: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of A431 cells with TAK1 antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Flow-Cytometry-NBP2-67180-img0001.jpg)
![Western Blot: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of TAK1 on human placenta tissue lysate using anti-TAK1 antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Western-Blot-NBP2-67180-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: TAK1 Antibody (JM73-19) [NBP2-67180] - Staining TAK1 in A431 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunocytochemistry-Immunofluorescence-NBP2-67180-img0002.jpg)
![Immunohistochemistry-Paraffin: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of paraffin-embedded human placenta tissue using anti-TAK1 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunohistochemistry-Paraffin-NBP2-67180-img0003.jpg)
![Immunohistochemistry-Paraffin: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of paraffin-embedded human prostate tissue using anti-TAK1 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunohistochemistry-Paraffin-NBP2-67180-img0004.jpg)